NCT06178614View on ClinicalTrials.gov

A Study of JNJ-87890387 for Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

March 16, 2027

Study Completion Date

July 21, 2028

Conditions
Advanced Solid Tumors
Interventions
DRUG

JNJ-87890387

JNJ-87890387 will be administered.

Trial Locations (6)

28041

RECRUITING

Hosp. Univ. 12 de Octubre, Madrid

37203

RECRUITING

Sarah Cannon Research Institute, Nashville

49546

RECRUITING

Start Midwest, Grand Rapids

69008

RECRUITING

Centre Leon Berard, Lyon

94805

RECRUITING

Institut Gustave Roussy, Villejuif

08035

RECRUITING

Hosp Univ Vall D Hebron, Barcelona

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY